GlobeNewsWire
02 Oct 2026, 15:46 UTC · 2h ago
Verdict
Headline takes no side. We score CATX +0.50 across one claim — strongly bullish.
+0.50strongly bullish
More positive than 70% of ticker scores this week
What the story claims
1 claim · scored −1 bearish … +1 bullish · 1 new · 0 priced in
Perspective Therapeutics will present data from its [212Pb]VMT01 program at the SITC 41st Annual Meeting from November 4 to 8, 2026.
Newpress release dated Oct 02, 2026
So whatThe full data release on November 3 creates a specific volatility catalyst for CATX within 32 days.
More positive than 66% of claims this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
![Perspective Therapeutics Announces Acceptance of [212Pb]VMT01 Data for Presentation at SITC 2026](https://images.financialmodelingprep.com/news/perspective-therapeutics-announces-acceptance-of-212pbvmt01-data-for-presentation-20261002.jpg)
Top 2 movers · tap to explore
More positive than 70% of ticker scores this week
The company's clinical data for its melanoma program was accepted for presentation at a major medical conference (SITC).
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
4h ago
+0.7%
Price agrees with the score
$2.74 vs $2.72 close before publication (Oct 1) · not market-adjusted
CATX chart →
